ID   LG1
AC   CVCL_XG18
DR   Wikidata; Q95982081
RX   PubMed=1915659;
RX   PubMed=2643097;
RX   PubMed=11888918;
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
RX   PubMed=1915659; DOI=10.1016/0014-4827(91)90489-H;
RA   Morgan T.L., Yang D.-J., Fry D.G., Hurlin P.J., Kohler S.K.,
RA   Maher V.M., McCormick J.J.;
RT   "Characteristics of an infinite life span diploid human fibroblast
RT   cell strain and a near-diploid strain arising from a clone of cells
RT   expressing a transfected v-myc oncogene.";
RL   Exp. Cell Res. 197:125-136(1991).
//
RX   PubMed=2643097; DOI=10.1073/pnas.86.1.187; PMCID=PMC286429;
RA   Hurlin P.J., Maher V.M., McCormick J.J.;
RT   "Malignant transformation of human fibroblasts caused by expression of
RT   a transfected T24 HRAS oncogene.";
RL   Proc. Natl. Acad. Sci. U.S.A. 86:187-191(1989).
//
RX   PubMed=11888918;
RA   Havre P.A., O'Reilly S., McCormick J.J., Brash D.E.;
RT   "Transformed and tumor-derived human cells exhibit preferential
RT   sensitivity to the thiol antioxidants, N-acetyl cysteine and
RT   penicillamine.";
RL   Cancer Res. 62:1443-1449(2002).
//